Last month in this space, we rounded up six months' worth of announced university licensing agreements in the pharmaceutical area. This month, we put together all the other license agreements between health care companies and academia—and the volume of deals doesn't even come close.
This isn't a fluke. Universities say that 80% of their dealmaking in health care is related to drug development—not least...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?